OpGen Inc (OPGN)

[chillswills37]

$OPGN They're buying. April 22, 2022 Arete Wealth Advisors LLC purchased a new stake in shares of OpGen, Inc. (NASDAQ:OPGN) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 50,000 shares of the medical research company’s stock, valued at approximately $54,000.

Recently, several other hedge funds have also added to their stakes in OPGN.
Why are they buying? There's only one reason to buy.

Millennium Management LLC purchased a new position in shares of OpGen in the 2nd quarter valued at approximately $80,000.

Bank of New York Mellon Corp raised its position in shares of OpGen by 229.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 40,559 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 28,242 shares during the last quarter.

Dimensional Fund Advisors LP purchased a new position in shares of OpGen in the 3rd quarter valued at approximately $154,000.

Citadel Advisors LLC raised its position in shares of OpGen by 46.7% in the 3rd quarter. Citadel Advisors LLC now owns 56,825 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 18,090 shares during the last quarter.

Renaissance Technologies LLC raised its position in shares of OpGen by 74.6% in the 3rd quarter. Renaissance Technologies LLC now owns 151,500 shares of the medical research company’s stock valued at $436,000 after purchasing an additional 64,747 shares during the last quarter.

7.74% of the stock is owned by institutional investors and hedge funds.

https://finnewslive.com/2022/04/22/arete-wealth-advisors-llc-purchases-shares-of-50000-opgen-inc-nasdaqopgn.html
OpGen partners $NVS $MRK $QGEN